Sun Pharma Q3FY22 numbers, Net Profit up 11.14%, above estimates For the quarter ending Dec 2021, consolidated net sales (including other operating income) of Sun Pharmaceuticals Industries has increased 11.61% to Rs 9863.06 crore compared to quarter ended Dec 2020. Operating profit margin has declined from 27.23% to 26.43%, leading to 8.32% rise in operating profit to Rs 2,606.33 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 16.22% to 17.62%. Purchase of finished goods cost fell from 9.87% to 8.14%. Employee cost decreased from 19.55% to 19.03%. Other expenses rose from 27.01% to 28.42%....